Active Ingredient History

  • Now
Risedronic acid is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. The action of risedronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Risedronate also targets farnesyl pyrophosphate (FPP) synthase. It is FDA approved for the treatment of postmenopausal osteoporosis, osteoporosis in men, glucocorticoid-induced osteoporosis and Paget’s disease. Calcium, antacids, or oral medications containing divalent cations interfere with the absorption of Risedronic acid. Common adverse reactions include rash, abdominal pain, constipation, diarrhea, indigestion, nausea, backache, urinary tract infectious disease and influenza-like illness.   NCATS

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)


$0.6648 - $20.1811

United States

$4.9109 - $65.8300
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( calcium carbonate, risedronate (actonel) )
2-(3-pyridinyl)-2-hydroxyethylidene-1,1-bisphosphonate | acide risédroniqe | acido risedronico | acidum risedronicum | actonel | atelvia | ne 58095 | ne-58095 | phosphonic acid, (2-hydroxy-2-(3-pyridinyl)ethylidene)bis-, disodium salt | residronate | ridron | risedronate | risedronate sodium | risedronate sodium anhydrous | risedronate sodium hemi-pentahydrate | risedronate sodium hydrate | risedronate sodium monohydrate | risedronic acid | risedronic acid monohydrate | risedronic acid monosodium salt | risedronsäure | risendronate | sodium risedronate | sodium risedronate hydrate


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue